Hot Products
| Catalog No. | Information |
| CFN93135 | Glabrolide Reference standards. |
| CFN93041 | Glabrone Glabrone shows antiviral activity against influenza virus. It also exhibits significant PPAR-gamma ligand-binding activity. |
| CFN99256 | Glaucin B Glaucin B is a new bitter limonoid. |
| CFN90408 | Glaucine Glaucine has antitussive, antioxidative potential and antiviral activities, it may be an anti-arthritic agent, it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity, attenuating IκBα and NF-κB activities. |
| CFN90207 | Glaucocalyxin A Glaucocalyxin A could potentially be developed as an antiplatelet and antithrombotic agent, can inhibit platelet p-selectin secretion and integrin activation by convulxin, is a GPVI selective ligand. Glaucocalyxin A has regulation of microglia activity, can attenuate lipopolysaccharide -stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathways.Glaucocalyxin A may become a potential anti-fibrotic agent in Idiopathic pulmonary fibrosis (IPF) management, it can effectively ameliorate pulmonary fibrosis through the antagonism of leukocyte infiltration and proinflammatory cytokine production. |
| CFN95299 | Glaucoside A Anticancer. Glaucoside A was evaluated against the HT-29 and HCT 116 human colon cancer cell lines. |
| CFN95300 | Glaucoside C Anticancer. Glaucoside C was evaluated against the HT-29 and HCT 116 human colon cancer cell lines. |
| CFN97977 | Glepidotin B Reference standards. |
| CFN80103 | Glibenclamide Glibenclamide is a known blocker of vascular ATP-sensitive K+ channels (KATP), used in the treatment of type 2 diabetes.Glibenclamide increases the risk for hypoglycemia by increasing insulin secretion, it plays a paradoxical protective role to protect against severe hypoglycemia-induced fatal cardiac arrhythmias; it also reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. |
| CFN95063 | Glicoricone Glicoricone acts as a partial estrogen antagonist. Glicoricone inhibited the monoamine oxidase with the IC50 values of 6.0 x 10(-5)-1.4 x 10(-4) M. |
